Opsonic Activity of Conservative Versus Variable Regions of the Group A Streptococcus M Protein

Polyacrylate–Peptide Antigen Conjugate as a Single-Dose Oral Vaccine against Group A Streptococcus

(2020) Mohammad Omer Faruck et al.   Vaccines

Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics

(2019) Mark R. Davies et al.   NATURE GENETICS

Volatile anesthetics affect macrophage phagocytosis

(2019) Hui Zha et al.   PLoS One

An Experimental Group A Streptococcus Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model

(2019) Tania Rivera-Hernandez et al.   mBio

Mucosal vaccines and technology

(2019) A. Miquel‐Clopés et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Cholic Acid-based Delivery System for Vaccine Candidates against Group A Streptococcus

(2019) Armira Azuar et al.   ACS Medicinal Chemistry Letters

Recent Advances in the Development of Peptide Vaccines and Their Delivery Systems Against Group A Streptococcus

(2019) Azuar et al.   Vaccines

Lipopeptide-Based Oral Vaccine Against Hookworm Infection

(2019) Stacey Bartlett et al.   JOURNAL OF INFECTIOUS DISEASES

Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study

(2019) Élodie Pastural et al.   VACCINE

Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial

(2018) Silvana Sekuloski et al.   PLoS One

Development of an opsonophagocytic killing assay for group a streptococcus

(2018) Scott Jones et al.   VACCINE

Protein adhesins as vaccine antigens for Group A Streptococcus

(2018) J M Raynes et al.   Pathogens and Disease

Polyglutamic acid-trimethyl chitosan-based intranasal peptide nano-vaccine induces potent immune responses against group A streptococcus

(2018) Reshma J. Nevagi et al.   Acta Biomaterialia

Development of an Opsonophagocytic Killing Assay Using HL-60 Cells for Detection of Functional Antibodies against Streptococcus pyogenes

(2018) Sanaz Salehi et al.   mSphere

Liposome-based intranasal delivery of lipopeptide vaccine candidates against group A streptococcus

(2016) Khairunnisa Abdul Ghaffar et al.   Acta Biomaterialia

DLS and zeta potential – What they are and what they are not?

(2016) Sourav Bhattacharjee   JOURNAL OF CONTROLLED RELEASE

Combinatorial Synthetic Peptide Vaccine Strategy Protects against Hypervirulent CovR/S Mutant Streptococci

(2016) Manisha Pandey et al.   JOURNAL OF IMMUNOLOGY

The Emerging Importance of IgG Fab Glycosylation in Immunity

(2016) Fleur S. van de Bovenkamp et al.   JOURNAL OF IMMUNOLOGY

Double adjuvanting strategy for peptide-based vaccines: trimethyl chitosan nanoparticles for lipopeptide delivery

(2016) Nirmal Marasini et al.   Nanomedicine

Streptococcal Immunity Is Constrained by Lack of Immunological Memory following a Single Episode of Pyoderma

(2016) Manisha Pandey et al.   PLoS Pathogens

Post-infectious group A streptococcal autoimmune syndromes and the heart

(2015) William John Martin et al.   AUTOIMMUNITY REVIEWS

Lipopeptide Nanoparticles: Development of Vaccines against Hookworm Parasite

(2015) Abdullah A. H. Ahmad Fuaad et al.   ChemMedChem

Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus

(2014) M. J. Walker et al.   CLINICAL MICROBIOLOGY REVIEWS

Challenges in mucosal vaccines for the control of infectious diseases

(2014) T. Azegami et al.   INTERNATIONAL IMMUNOLOGY

Targeting TLR2 for Vaccine Development

(2014) Afonso P. Basto et al.   Journal of Immunology Research

Effects of pre-existing anti-carrier immunity and antigenic element multiplicity on efficacy of a modular virus-like particle vaccine

(2013) Yap P. Chuan et al.   BIOTECHNOLOGY AND BIOENGINEERING

Strategies in the development of vaccines to prevent infections with group A streptococcus

(2013) Michael F Good et al.   Human Vaccines & Immunotherapeutics

Immunostimulation by Synthetic Lipopeptide-Based Vaccine Candidates: Structure-Activity Relationships

(2013) Mehfuz Zaman et al.   Frontiers in Immunology

Immunological Evaluation of Lipopeptide Group A Streptococcus (GAS) Vaccine: Structure-Activity Relationship

(2012) Mehfuz Zaman et al.   PLoS One

New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci

(2011) James B. Dale et al.   VACCINE

Relationship of in vitro phagocytosis of serotype 14 Streptococcus pneumoniae to specific class and IgG subclass antibody levels in healthy adults

(2010) J. E. LORTAN et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Lipid Core Peptide System for Gene, Drug, and Vaccine Delivery

(2009) Wei Zhong et al.   AUSTRALIAN JOURNAL OF CHEMISTRY

CD40 Ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides

(2008) Tahamtan Ahmadi et al.   IMMUNOLOGY